ChemicalBook--->CAS DataBase List--->1074-97-1

1074-97-1

1074-97-1 Structure

1074-97-1 Structure
IdentificationBack Directory
[Name]

4,6-Dihydroxypyrimidine-5-carboxamide
[CAS]

1074-97-1
[Synonyms]

4,6-Dihydroxypyrimidine-5-carboxamide
2,4-dihydroxypyrimidine-5-carboxamide
2,4-dioxo-1,2,3,4-tetrahydropyriMidine-5-carboxaMide
1,2,3,4-Tetrahydro-2,4-dioxo-5-pyrimidinecarboxamide
5-Pyrimidinecarboxamide, 1,2,3,4-tetrahydro-2,4-dioxo-
[Molecular Formula]

C5H5N3O3
[MOL File]

1074-97-1.mol
[Molecular Weight]

155.11
Hazard InformationBack Directory
[Uses]

2,4-Dihydroxypyrimidine-5-carboxamide is a building block related to Favipiravir(F103350). Favipiravir is used for the treatment of advanced Ebola virus infection in a small animal model. Favipiravir suppressed the replication of Zaire Ebola virus and prevented a lethal outcome in 100% of the animals. Based on the studies, Favipiravir can be a candidate for the treatment of Ebola hemorrhagic fever.
1074-97-1 suppliers list
Company Name: Nanjing Chemlin Chemical Co., Ltd  
Tel: 025-83697070
Website: www.echemlin.cn
Company Name: Adobe Chem Co., Ltd.  
Tel: 2332782371
Website: www.adobechem.cn
Company Name: Shanghai Amico Chemicals Co. LTD  
Tel: 18019252918
Website: www.amkchem.com 微信:17321281695
Company Name: Nanjing Puruida Pharmaceutical Technology Co., Ltd.  
Tel: 15905142898
Website: www.prdchem.com/
Tags:1074-97-1 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.